Home » Gilead’s Candidate Under EMA Review
Gilead’s Candidate Under EMA Review
Gilead Sciences announced that the European Medicines Agency has accepted for review the marketing authorization application filed by the company for its HIV combination pill, Quad.
Zacks
Zacks
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May